Avadomide
Avadomide (CC-122) is an orally bioavailable cereblon-modulating agent with potential antineoplastic properties. It is utilized in cancer research, particularly in hematological malignancies, to study its immunomodulatory and tumoricidal effects in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1015474-32-4
Product Name Alternative
Diffuse, DLBCL, E2Enzyme, E3 Enzyme, E3 Ligase, E2 conjugating enzyme, E2 Enzyme, E1Enzyme, E1 Enzyme, E1/E2/E3 Enzyme, E1 activating enzyme, CC 122, CC-122, CC122, cereblon, Apoptosis, Avadomide, antitumor, B-cell, Inhibitor, large, E3 ligating enzyme, E3Enzyme, LigandforE3Ligase, ligase, Ligand for E3 Ligase, inhibit, immunomodulatory, lymphoma, orally, Ubiquitin conjugating enzyme, Ubiquitin ligase, Ubiquitin activating enzyme
Field of Research
Cell Biology, Pharmacology & Drug Discovery, Protein Biochemistry, Signal Transduction
Purity
99.07% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.99 mM) ; Ethanol:1 mg/mL (3.49 mM) ; DMSO:52 mg/mL (181.63 mM)
Smiles
Cc1nc2cccc (N) c2c (=O) n1C1CCC (=O) NC1=O
Molecular Formula
C14H14N4O3
Molecular Weight
286.29
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
034211-HRP 200 µL
CREBL1, CT (ATF6B, CREBL1, G13, Cyclic AMP-dependent transcription factor ATF-6 beta, Activating transcription factor 6 beta, Protein G13, cAMP response element-binding protein-related protein, cAMP-responsive element-binding protein-like 1, Processed cyclic AMP-dependent transcription factor ATF-6 beta) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details 
bs-7083R-PE-Cy5 100 µL
CARD14 Polyclonal Antibody, PE-Cy5 Conjugated
Sign In for Pricing
View Details